Sorafenib-induced Prostate Volume Reduction, a New Adverse Effect Detected by Imaging: A Pilot Study

BACKGROUND: Sorafenib has been used in the treatment of advanced hepatocellular carcinoma (HCC) and renal cell carcinoma (RCC). Sorafenib-associated organ reduction have been reported on imaging, such as thyroid, pancreas and muscle, but there has been no research on prostate volume reduction (PVR)....

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Hiroaki, Masuoka, Sota, Nasu, Katsuhiro, Mori, Kensaku, Kojima, Takahiro, Fukuda, Kuniaki, Takahashi, Kazuhiro, Ishiguro, Toshitaka, Hosokawa, Takahiro, Minami, Manabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ubiquity Press 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208293/
https://www.ncbi.nlm.nih.gov/pubmed/30386849
http://dx.doi.org/10.5334/jbsr.1607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208293/
https://www.ncbi.nlm.nih.gov/pubmed/30386849
http://dx.doi.org/10.5334/jbsr.1607

Ejemplares similares